Stock Rich List
#506 on the corporate holders of 809 holders

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

10% owner at Braveheart Bio; 10% owner at Kailera Therapeutics.

$167M
in disclosed stock, +$5.1M (+3.14%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
506th of 809
Companies held
2
Largest holding
BRVE, 85.9% of total
Latest SEC filing
Aug 7, 2026
Listed but not counted
$12

What the $167M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Braveheart Bio BRVE
Common Stock
Directly7,420,091$19.27$143M85.9%Form 4, Aug 7, 2026
Kailera Therapeutics KLRA
Common Stock
Directly2,034,133$11.58$23.6M14.1%Form 4, Apr 20, 2026

Share counts are the amounts Jiangsu Hengrui Pharmaceuticals Co., Ltd. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Kailera Therapeutics KLRA
Common Stock
Through Hengrui (USA) Ltd.
Held by a company or fund the insider manages
1$11.58$12—Form 4, Apr 20, 2026

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
503ARG Private Equity, LLC
Insider, StepStone Group
$168M+$881K (+0.53%)
504Trimaran Pollo Partners, L.L.C.
10% owner, El Pollo Loco Holdings
$168M−$8.4M (−4.77%)
505Bay Resource Partners LP
10% owner, Cracker Barrel Old Country Store
$167M−$6.2M (−3.59%)
506Jiangsu Hengrui Pharmaceuticals Co., Ltd.
10% owner, Braveheart Bio
$167M+$5.1M (+3.14%)
507Silver Lake Partners V DE (AIV), L.P.
Director, Dell Technologies
$164M−$300K (−0.18%)
508Nea 14 Gp, LTD
10% owner, Enliven Therapeutics
$164M+$5.4M (+3.39%)
509Bay II Resource Partners LP
10% owner, Cracker Barrel Old Country Store
$164M−$6.1M (−3.59%)

Other Braveheart Bio insiders

All BRVE insiders

Questions

How much stock does Jiangsu Hengrui Pharmaceuticals Co., Ltd. own?

Jiangsu Hengrui Pharmaceuticals Co., Ltd. holds $166,540,414 in listed stock based on SEC filings and current prices, mostly Braveheart Bio (BRVE). That ranks 506th on the Stock Rich List.

Is this Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.